reference/24140052

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24140052

Outgoing Links

Predicate	Object
contentType	Journal Article\|Review
endingPage	549
issn	1078-1439
issueIdentifier	5
pageRange	543-549
publicationName	Urologic Oncology: Seminars and Original Investigations
startingPage	543
bibliographicCitation	Rini BI, Flaherty K. Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations. 2008 Sep;26(5):543–9. doi: 10.1016/j.urolonc.2008.03.012.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25b20ac33314b2c738ccf01773a2da16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5329d01956a0ee435472a7dc26d6e7be
date	200809
identifier	https://doi.org/10.1016/j.urolonc.2008.03.012 https://pubmed.ncbi.nlm.nih.gov/18774471
isPartOf	https://portal.issn.org/resource/ISSN/1078-1439 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21529
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma
discusses	http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007680Q000188 http://id.nlm.nih.gov/mesh/D002292Q000188 http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016503 http://id.nlm.nih.gov/mesh/D002986
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361911 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361902 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132274070 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361839 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361808 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145712265 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25200276 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168012331 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54608508 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18293306 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23375915 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122362113 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918289 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24847874 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86277830 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137295275 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86287409 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361806 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148191 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361790 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23308413 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361737 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168317584 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361642 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361634 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129317846 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53486199 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71433778 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23724530 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163359784 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166639522 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4fb3b68e84149f91bcfd0102f95d3731 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128611606 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244328266 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247499656 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248184126

Total number of triples: 69.